Immunologic assessments from ARTEMIS: A European, phase 3, randomized, double-blind, placebo-controlled trial of AR101 in peanut-allergic subjects aged 4–17 years
Authors:
- C. Delebarre SauvageCSC. Delebarre Sauvage
- C. NilssonCNC. Nilsson
- K. BeyerKBK. Beyer
- M. Fernández-RivasMFM. Fernández-Rivas
- G. du ToitGTG. du Toit
- P.J. TurnerPTP.J. Turner
- K. BlümchenKBK. Blümchen
- M. Dolores IbáñezMIM. Dolores Ibáñez
- A. DeschildreADA. Deschildre
- A. MuraroAMA. Muraro
- V. SharmaVSV. Sharma
- M. Erlewyn-LajeunesseMEM. Erlewyn-Lajeunesse
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 61 (5) , 340-341
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
- European Commission
- Ministerio de Economía y Competitividad